CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy doubled in the fourth quarter, but the Danish ...

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

Jeremy Clarkson has revealed he’s doing “everything in his power to not die” following his heart surgery last year. The ...

Novo Nordisk stock jumped early Wednesday after the weight-loss drugs leader reported adjusted earnings of 88 cents per share ...

Hollywood actress Amy Schumer has opened up about her experience using the popular Type 2 diabetes drug, Ozempic.

A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...

Amy Schumer revealed she stopped using the weight-loss drug Ozempic due to severe side effects, including nausea and extreme fatigue. She later discovered a genetic marker made her more susceptible to ...

Actress and comedian Amy Schumer said she took Ozempic three years ago and quickly lost 30 lbs. However, she quit the ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Novo Nordisk A/S expects sales to surge again this year as the Danish drugmaker builds supply for blockbuster diabetes ...